Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genomic and Transcriptomic Characterization Revealed the High Sensitivity of Targeted Therapy and Immunotherapy in a Subset of Endometrial Stromal Sarcoma

2 Feb 2023

Abstract excerpt

PURPOSE: The unique chromosomal rearrangements of endometrial stromal sarcoma (ESS) make it possible to distinguish high-grade ESS (HGESS) and low-grade ESS (LGESS) from the molecular perspective. Analysis of ESS at the genomic and transcriptomic levels can help us achieve accurate diagnosis of ESS and provide potential therapy options for ESS patients. Materials and Methods: A total of 36 ESS patients who...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Endometrial and Cervical Cancer Treatments
Share to Sarcoma Diagnosis and Treatment
Share to Uterine Myomas and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 36731460
DOI: 10.4143/crt.2022.1647

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genomic and Transcriptomic Characterization Revealed the High Sensitivity of Targeted Therapy and Immunotherapy in a Subset of Endometrial Stromal SarcomaPMID 36731460Read ↗

Integrated mutational landscape analysis of endometrial stromal sarcoma.Semantic proximity Read ↗

Endometrial stromal sarcoma – the new genetic paradigmSemantic proximity Read ↗

ESR1 hotspot mutations in endometrial stromal sarcoma with high-grade transformation and endocrine treatment.Semantic proximity Read ↗

Immunohistochemical and Molecular Characterization of Endometrial Stromal SarcomasSemantic proximity Read ↗

Molecular Classification of Endometrial Stromal Sarcomas Using RNA Sequencing Defines Nosological and Prognostic Subgroups with Different Natural HistorySemantic proximity Read ↗

Molecular pathogenesis and prognostication of "low‐grade'' and "high‐grade" endometrial stromal sarcomaSemantic proximity Read ↗

Targeted RNA Sequencing Highlights a Diverse Genomic and Morphologic Landscape in Low-grade Endometrial Stromal Sarcoma, Including Novel Fusion GenesSemantic proximity Read ↗

Uterine carcinosarcoma: Contemporary clinical summary, molecular updates, and future research opportunity.Semantic proximity Read ↗

Comprehensive Review of Endometrial Cancer: New Molecular and FIGO Classification and Recent Treatment ChangesSemantic proximity Read ↗

JAZF1/SUZ12 gene fusion in endometrial stromal sarcomasSemantic proximity Read ↗

Molecular biomarkers for uterine leiomyosarcoma and endometrial stromal sarcomaSemantic proximity Read ↗

Endometrial stromal tumors: the new WHO classification.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.